Monday - Friday 08:00 a.m - 06:00 p.m

Does Radiation Therapy Cause Erectile Dysfunction?

Yes, it can. However, not all men develop erectile dysfunction after radiation therapy for prostate cancer.

This is one of the most common questions that comes up during an initial consultation. It is also one of the topics surrounded by the most misinformation. Some patients arrive convinced that erectile dysfunction is inevitable. Others believe that modern radiation techniques have completely eliminated this risk. Neither of these assumptions is accurate.

Why Is This a Concern?

The prostate is surrounded by structures involved in sexual function. For that reason, any treatment directed at the prostate—whether surgery or radiation therapy—has the potential to affect a man’s ability to achieve or maintain an erection.

This concern is entirely understandable. Most men are not only interested in controlling their cancer; they also want to preserve their quality of life after treatment.

What Does the Scientific Evidence Show?

One of the most important studies in localized prostate cancer is the PROTECT trial, which followed more than 1,600 men treated with active monitoring, surgery, or radiation therapy.

The study found that both surgery and radiation therapy can affect sexual function. However, the pattern of change tends to be different. Following surgery, erectile dysfunction often occurs earlier. After radiation therapy, when changes do occur, they generally develop more gradually over time.

Quality-of-life outcomes reported by Donovan and colleagues in The New England Journal of Medicine demonstrated this pattern clearly.

What Factors Actually Influence the Risk?

Radiation therapy is only one part of the equation.

Age plays a significant role.

Other important factors include diabetes, high blood pressure, vascular disease, smoking history, and erectile function before treatment begins.

Hormone therapy is another key consideration. Some patients require medications that temporarily lower testosterone levels to improve cancer control. In these situations, reduced sexual desire and worsening erectile function may occur independently of the radiation treatment itself.

This is why two men with the same diagnosis can have very different experiences after treatment.

Have Modern Radiation Techniques Reduced This Risk?

Yes.

Many of the older studies evaluated patients who were treated before the widespread use of IMRT, IGRT, and other advanced radiation planning techniques.

Today, radiation can be delivered with much greater precision, reducing the dose received by nearby healthy tissues. This has helped decrease treatment-related toxicity, although it has not eliminated the possibility of side effects altogether.

What Does This Mean for You?

If you are considering radiation therapy for prostate cancer, the most useful information is not necessarily the average experience of thousands of patients.

The most useful information is understanding your own situation.

Your age, overall health, baseline sexual function, and whether hormone therapy will be part of your treatment all help determine what you can realistically expect after therapy.

For that reason, this topic should be discussed before treatment begins—not after it is already underway.

Conclusion

Radiation therapy can affect erectile function, but the risk is not the same for every patient.

The available evidence shows that multiple factors influence this outcome and that modern treatment techniques have reduced some of the toxicity seen in earlier decades.

If this is a concern for you, it is worth discussing during your first consultation. Realistic expectations are often more helpful than relying on isolated stories found online.

References

Donovan JL, Hamdy FC, Lane JA, et al. Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. New England Journal of Medicine. 2016;375(15):1425–1437. doi:10.1056/NEJMoa1606221

Hamdy FC, Donovan JL, Lane JA, et al. 15-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. New England Journal of Medicine. 2023;388(8):718–732. doi:10.1056/NEJMoa2214122

Share:

Share this post
Prevention campaign

Help us save lives
yes to health